Infermedica is now expanding its operations to the Middle East and beyond. They will be introducing a new language version of their flagship diagnostic technology. It will make the AI-driven symptom checker available to thousands of millions of users across the globe who speak Arabic.
The language will be available for all of the Infermedica’s products such as Medical API, Call Center Triage, and Symptom Checker. This update will follow their staple launch in other languages such as English, Simplified Chinese, Italian, Spanish, Portuguese, French, and German among others.
With an already top-level portfolio, Infermedica is now trying to bridge the growing gaps in accessing care. The company is now planning to offer advanced triage and preliminary diagnosis tools to health systems providers, hospitals, and insurance companies. This will help them to guide patients to the appropriate form of care.
The bigger objective here is to improve the overall performance of customers, enhance healthcare accessibility, and cut down costs. According to the chief executive Piotr Orzechowsic, currently, more than four million consumers are using Infermedica’s tools.
Infermedica’s flagship product is a symptom checker. This product allows patients to carry out a basic diagnostic interview. After collecting data, the AI then suggests the most appropriate and cost-effective action to undertake. Actions may involve calling or visiting a doctor, visiting an emergency department while experiencing some serious symptoms, or take some self-care treatment. The company provides two complementary solutions for healthcare service providers.
Why Offer Services in Arabic?
World Bank states the Middle East is one of the regions with the maximum gap for supply-demand services in healthcare. The newest figures show that the distribution of doctors per capita is around the ratio of 2.4 in Saudi Arabia and the UAE. It is lower than 1.0 in Yemen, Iraq, Egypt, or Bahrain. Thus, making services available in Arabic makes more sense for framing future strategies of the company.